---
title: "Publications"
date: 2020-10-15T12:08:40+02:00
---

<a href="https://goo.gl/tvIoC2"> <i class="ai ai-google-scholar ai-3x"> </i> </a>
<a href="https://goo.gl/kvodaz/"> <i class="ai ai-pubmed ai-2x ai-3x"> </i> </a>

---

# Forthcomming

- Jansky, S, **Sharma, AK** , Körber V, Toprak, UH, Gartlgruber, M, Greco, A, Quintero, A, Chomsky, E, Henrich, K, Tanay, A, Herrmann, C, Höfer, T, Westermann, F. _Developmental programs in childhood neuroblastoma._ **Accepted in Nature Genetics** (2020)

- Carlos Ramirez Alvarez, **Sharma, AK**, Carmon Kee, Leonie Thomas, Steeve Boulant, Carl Herrmann. [SPINT2 controls SARS-CoV-2 viral infection and is associated to disease severity.](https://doi.org/10.1101/2020.12.28.424029) **bioRxiv** (2021).

- Elena A. Afanasyeva, Moritz Gartlgruber, Tatsiana Ryl, Gregor Mönke, Bieke Decaesteker, Geertrui Denecker, Andres Florez, Alica Torkov, Daniel Dreidax, Carl Herrmann, Umut Toprak, Konstantin Okonechnikov, Sara Ek, **Sharma, AK**, Vitaliya Sagulenko, Frank Speleman, Kai-Oliver Henrich, Frank Westermann. _Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma._ **Accepted in Life Science Alliance** (2021)

# Available online
1. Gartlgruber, M, **Sharma, AK** ,  Quintero, A,  Dreidax, D,  Jansky, S,  Park, Y, Gogolin, S, Meder, J,  Doncevic D,  Saary P,  Toprak, UH,   Ishaque, N,  Afanasyeva, E, Koster, J,  Versteeg R,  Grünewald, TGP, Jones, DTW, Pfister, SM, Henrich, K, Nes, Jv, Herrmann, C, Westermann, F. [Super enhancers define regulatory subtypes and cell identity in neuroblastoma.](https://rdcu.be/cetzn) **Nature Cancer** (2020)

2. Emanuel Schwarz, Dag Alnæs, Ole A. Andreassen, Han Cao, Junfang Chen, Franziska Degenhardt, Dominic Dwyer, Roland Eils, Jeanette Erdmann, Carl Herrmann, Martin Hofmann-Apitius, Tobias Kaufmann, Nikolaos Koutsouleris, Alpha T. Kodamullil, Adyasha Khuntia, Maria L. Munoz-Venegas, Markus M. Nöthen, Riya Paul, Andres Quintero, Heribert Schunkert, **Sharma AK**, Heike Tost, Lars T. Westlye, Youcheng Zhang, Andreas Meyer-Lindenberg. [Identifying multimodal signatures underlying the somatic comorbidity of psychosis: the COMMITMENT roadmap.](https://pubmed.ncbi.nlm.nih.gov/33060817/) **Molecular Psychiatry** (2020)

3. Ansari, SS, **Sharma, AK**, Ali,D, Eibl, H, Soni, H, Tews, B, König, R, Berger, MR. [Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833417/). **Cell Death and Disease** (2018)

4. Ansari, S. S., **Sharma, AK**, Zepp, M., Ivanova, E., Bergmann, F., König, R., Berger, M. R. [Upregulation of cell cycle genes in head and neck cancer patients may be antagonized by erufosine’s down regulation of cell cycle processes in OSCC cells](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814175/). **Oncotarget** (2017)

5. **Sharma AK**, Eils R and König R. [Copy number alterations in enzyme-coding and cancer-causing genes reprogram tumor metabolism.](http://www.ncbi.nlm.nih.gov/pubmed/27216182) **Cancer Research** (2016)

6. **Sharma AK** [Computational Analysis of Metabolic Reprogramming in Tumors.](http://www.ub.uni-heidelberg.de/archiv/20332) **Doctoral Dissertation**,  (2016)

7. Shukla K, <b>Sharma AK</b>, Ward A, Will R, Hielscher T, Balwierz A, Breunig C, Münstermann E, König R, Keklikoglou I and Wiemann S. [MicroRNA-30c-2-3p negatively regulates NF-κB signaling and cell cycle progression through downregulation of TRADD and CCNE1 in breast cancer.](http://www.ncbi.nlm.nih.gov/pubmed/25732226) **Molecular Oncology** (2015)

8. Khandelwal N, Breinig M, Speck T, Michels T, Kreutzer C, Sorrentino A, **Sharma AK**, Umansky L, Conrad H, Poschke I, Offringa R, König R, Bernhard H, Machlenkin A, Boutros M and Beckhove P. [A high-throughput RNAi screen for detection of immune checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes.](http://www.ncbi.nlm.nih.gov/pubmed/25691366) **EMBO Molecular Medicine** (2015)

9. Ummanni R, Mannsperger HA, Sonntag J, Oswald M, **Sharma AK**, König R, Korf U. [Evaluation of reverse phase protein array (RPPA)–based pathway activation profiling in 84 non–small cell lung cancer (NSCLC) cell lines as platform for cancer proteomics and biomarker discovery.](http://www.ncbi.nlm.nih.gov/pubmed/24361481) **Biochimica et Biophysica Acta (BBA)–Proteins and Proteomics** (2014)

10. **Sharma AK** and König R. [Metabolic network modeling approaches for investigating the "hungry cancer".](http://www.ncbi.nlm.nih.gov/pubmed/23680724) **Seminars in Cancer Biology** (2013)

---
